Filing Details
CVS HEALTH Corp (NYSE:CVS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 04, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNYSE:CVS
CVS HEALTH Corp (CVS) Files Quarterly Report for Q0
CVS HEALTH Corp (NYSE:CVS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 04, 2026.
At publication ·
What changed
CVS HEALTH Corp (NYSE:CVS) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- CVS HEALTH Corp filed its quarterly report (Form 10-Q) with the SEC on November 04, 2026.
- The company's stock trades at $91.41 with a market capitalization of $102.6 billion.
- The 10-Q filing includes unaudited financial statements and management commentary on recent business performance and emerging trends.
Market Context
CVS HEALTH Corp's stock currently trades at $91.41 with a market capitalization of $102.6B.
The 10-Q provides CVS HEALTH Corp's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for CVS HEALTH Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CVS Stock Page
Frequently Asked Questions
Where can I read CVS's SEC filings?
Browse all filings on our CVS SEC filings page.
What types of SEC filings does CVS HEALTH Corp file?
Public companies like CVS HEALTH Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
